chr10-113553052-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001177660.3(HABP2):c.-10+2091T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.341 in 1,067,296 control chromosomes in the GnomAD database, including 65,312 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.33 ( 8406 hom., cov: 33)
Exomes 𝑓: 0.34 ( 56906 hom. )
Consequence
HABP2
NM_001177660.3 intron
NM_001177660.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.84
Publications
8 publications found
Genes affected
HABP2 (HGNC:4798): (hyaluronan binding protein 2) This gene encodes a member of the peptidase S1 family of serine proteases. The encoded preproprotein is secreted by hepatocytes and proteolytically processed to generate heavy and light chains that form the mature heterodimer. Further autoproteolysis leads to smaller, inactive peptides. This extracellular protease binds hyaluronic acid and may play a role in the coagulation and fibrinolysis systems. Mutations in this gene are associated with nonmedullary thyroid cancer and susceptibility to venous thromboembolism. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 10-113553052-T-C is Benign according to our data. Variant chr10-113553052-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 298892.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.45 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.330 AC: 50035AN: 151808Hom.: 8401 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
50035
AN:
151808
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.343 AC: 314105AN: 915368Hom.: 56906 Cov.: 12 AF XY: 0.351 AC XY: 166516AN XY: 474072 show subpopulations
GnomAD4 exome
AF:
AC:
314105
AN:
915368
Hom.:
Cov.:
12
AF XY:
AC XY:
166516
AN XY:
474072
show subpopulations
African (AFR)
AF:
AC:
6958
AN:
22582
American (AMR)
AF:
AC:
9055
AN:
40396
Ashkenazi Jewish (ASJ)
AF:
AC:
8944
AN:
21972
East Asian (EAS)
AF:
AC:
8185
AN:
36914
South Asian (SAS)
AF:
AC:
34471
AN:
72760
European-Finnish (FIN)
AF:
AC:
16971
AN:
52580
Middle Eastern (MID)
AF:
AC:
2253
AN:
4646
European-Non Finnish (NFE)
AF:
AC:
212317
AN:
621428
Other (OTH)
AF:
AC:
14951
AN:
42090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
9886
19771
29657
39542
49428
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4966
9932
14898
19864
24830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.330 AC: 50064AN: 151928Hom.: 8406 Cov.: 33 AF XY: 0.331 AC XY: 24575AN XY: 74256 show subpopulations
GnomAD4 genome
AF:
AC:
50064
AN:
151928
Hom.:
Cov.:
33
AF XY:
AC XY:
24575
AN XY:
74256
show subpopulations
African (AFR)
AF:
AC:
12771
AN:
41378
American (AMR)
AF:
AC:
4524
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
1418
AN:
3472
East Asian (EAS)
AF:
AC:
994
AN:
5172
South Asian (SAS)
AF:
AC:
2247
AN:
4822
European-Finnish (FIN)
AF:
AC:
3358
AN:
10534
Middle Eastern (MID)
AF:
AC:
143
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23488
AN:
67960
Other (OTH)
AF:
AC:
783
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1761
3522
5282
7043
8804
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
516
1032
1548
2064
2580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1103
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Factor VII Marburg I Variant Thrombophilia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.